1-11 of 11
Rajesh Belani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Late Polyclonal P-BCMA-101 CAR-T Cell Re-Expansion and Rapid Complete Response in a Patient with Relapsed Multiple Myeloma Treated with One Cycle of Talquetamab, More Than 3 Years after CAR-T Infusion

Anupama Deepa Kumar, Ajai Chari, Srishti Gupta, Joseph Rohr, Rajesh Belani, Blair Madison, Zhibo Ma, Chris E Martin, Katherine McArthur, Hilary Ostwald, Syed Rizvi, Thomas G Martin
Journal: Blood
Blood (2024) 144 (Supplement 1): 2083.
https://doi.org/10.1182/blood-2024-211578
Published: 2024
Journal Articles

P-CD19CD20-ALLO1: Potent Fully Allogeneic CAR-T Therapy Targeting CD19 and CD20 with Superior Efficacy over Single-Target Products

Samy Jambon, Jennifer Ruiz, Andres Garcia-Maldonado, Meixuan Chen, Danny Mendoza, Garrett Arauz, Nicholas DeMarco, Mona Connerney, Jeff D Eskew, Rajesh Belani, Stacey A Cranert, Julia Coronella, Devon J Shedlock
Journal: Blood
Blood (2024) 144 (Supplement 1): 4805.
https://doi.org/10.1182/blood-2024-211441
Published: 2024
Journal Articles

A Phase 1 Study of P-BCMA-ALLO1, a Non-Viral, Allogeneic BCMA Directed CAR-T in Relapsed/Refractory Multiple Myeloma (RRMM): Results from Optimized Lymphodepletion Cohort

Bhagirathbhai Dholaria, Leyla O. Shune, Mehmet H. Kocoglu, Andrew Kin, Aravind Ramakrishnan, Ehsan Malek, Siddhartha Ganguly, Christopher Strouse, Jose Carlos Cruz, Edward Anthony Faber, Katherine McArthur, Jeff D Eskew, Joanne McCaigue, Samuel DePrimo, Chris E Martin, Sabrina Haag, Hamid Namini, Ellen Christie, Rajesh Belani, Syed Rizvi, Stacey A Cranert, Julia Coronella, Devon J Shedlock, Caitlin Costello
Journal: Blood
Blood (2024) 144 (Supplement 1): 4828.
https://doi.org/10.1182/blood-2024-207459
Published: 2024
Journal Articles

Early Safety Results of P-BCMA-ALLO1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (CAR-T), in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)

Bhagirathbhai Dholaria, Mehmet H. Kocoglu, Andrew Kin, Adam S. Asch, Aravind Ramakrishnan, Carlos Bachier, Tulio E. Rodriguez, Leyla Shune, Katherine McArthur, Joanne McCaigue, Samuel DePrimo, Chris Martin, Sabrina Haag, Maggie Zhang, Hamid Namini, Ellen Christie, Rajesh Belani, Stacey A Cranert, Julia Coronella, Devon J Shedlock, Caitlin L. Costello
Journal: Blood
Blood (2023) 142 (Supplement 1): 3479.
https://doi.org/10.1182/blood-2023-182430
Published: 2023
Journal Articles

Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System

Caitlin Costello, Ben A Derman, Mehmet Hakan Kocoglu, Abhinav Deol, Abbas Abbas Ali, Tara Gregory, Bhagirathbhai Dholaria, Jesus G Berdeja, Adam D Cohen, Krina K. Patel, David S. Siegel, Rajneesh Nath, Katherine McArthur, Joanne McCaigue, Christopher E Martin, Majid Ghoddusi, Hamid Namini, Eric M. Ostertag, Matthew A. Spear, Rajesh Belani, Nina Shah
Journal: Blood
Blood (2021) 138 (Supplement 1): 3858.
https://doi.org/10.1182/blood-2021-151672
Published: 2021
Journal Articles

Progression Free Survival of Relapsed or Refractory Multiple Myeloma (RRMM) after Failure of Three Prior Lines of Therapy in United States (US) Real-World Practice

Christopher Kim, PhD, Megan Braunlin, MPH, Rajesh Belani, MD, John Travis Wheeling, MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-140549
Published: 2020
Journal Articles

Trends in the Multiple Myeloma Treatment Landscape: A United States Analysis of Oscer Electronic Health Record Data 2011-2019

Megan Braunlin, MPH, Rajesh Belani, MD, Jacqueline Buchanan, John Travis Wheeling, MPH, Christopher Kim, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4722.
https://doi.org/10.1182/blood-2019-125972
Published: 2019
Journal Articles

A Survey of Oncologist's Opinions and Perceptions Regarding the Use of Granulocyte-Colony Stimulating Factors (G-CSFs) Among Patients Receiving Myelosuppressive Chemotherapy

Alicia Hawkins, Alysa Murphy, BS, Michelle McNamara, BSc, Prasad L Gawade, MBBS, PhD, Rajesh Belani, MD, Michael A Kelsh, PhD MPH, MA
Journal: Blood
Blood (2018) 132 (Supplement 1): 5807.
https://doi.org/10.1182/blood-2018-99-115082
Published: 2018
Journal Articles

Extracellular Tyrosyl-tRNA Synthetase Is a Potent Stimulator of Thrombocytopoiesis

Sachiko Kanaji, MD PhD, Taisuke Kanaji, MD PhD, My-Nuong Vo, PhD, Alessandro Zarpellon, PhD, Ryan Shapiro, Rajesh Belani, MD, Minh-Ha Do, PhD, Xiang-Lei Yang, PhD, Zaverio M. Ruggeri, MD, Paul Schimmel, PhD
Journal: Blood
Blood (2016) 128 (22): 1476.
https://doi.org/10.1182/blood.V128.22.1476.1476
Published: 2016
Journal Articles

Novel Protein Agonist of Thrombopoiesis Acts Via a Physiocrine Pathway Distinct From That of Thrombopoietin

Minh-Ha T Do, PhD, Wei Zhang, PhD, Kyle Chiang, PhD, Chi-Fang Wu, PhD, Chulho Park, PhD, Quansheng Zhou, MD/PhD, My-Nuong Vo, PhD, Xiang-Lei Yang, PhD, Lori Kunkel, MD, Melissa A Ashlock, MD, John D Mendlein, PhD, Rajesh Belani, MD, Alain P Vasserot, PhD, Jeffry D Watkins, PhD
Journal: Blood
Blood (2011) 118 (21): 2376.
https://doi.org/10.1182/blood.V118.21.2376.2376
Published: 2011
Journal Articles

Measurement of Blood-Borne Tissue Factor Procoagulant Activity in Healthy Individuals and Cancer Patients Using a Novel Assay.

Rachel E. Tilley, PhD, Todd Holscher, BSc, Rajesh Belani, MD, Jorge Nieva, MD, Nigel Mackman, PhD
Journal: Blood
Blood (2005) 106 (11): 1938.
https://doi.org/10.1182/blood.V106.11.1938.1938
Published: 2005